Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.68B |
| 2 |
Synchrony
SYF
|
+$441M |
| 3 |
Meta Platforms (Facebook)
META
|
+$370M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$349M |
| 5 |
Comcast
CMCSA
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$783M |
| 2 |
Morgan Stanley
MS
|
+$518M |
| 3 |
Lowe's Companies
LOW
|
+$474M |
| 4 |
Visa
V
|
+$425M |
| 5 |
Netflix
NFLX
|
+$419M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.01% |
| 2 | Technology | 4.76% |
| 3 | Consumer Discretionary | 3.82% |
| 4 | Industrials | 3.81% |
| 5 | Communication Services | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5501
PUT
Integer Holdings
ITGR
$4.26B
| $793K | ﹤0.01% |
10,400
-12,700
| -55% | -$1.02M |
|
5502
PUT
Impinj
PI
$5.28B
| $793K | ﹤0.01% |
54,500
+10,700
| +24% | +$210K |
|
5503
Tejon Ranch
TRC
$442M
| $793K | ﹤0.01% |
47,855
+14,511
| +44% | +$270K |
|
5504
Aurinia Pharmaceuticals
AUPH
$2.06B
| $792K | ﹤0.01% |
116,158
-20,029
| -15% | -$115K |
|
5505
CALL
BWX Technologies
BWXT
$15.9B
| $792K | ﹤0.01% |
20,700
+8,500
| +70% | +$422K |
|
5506
PUT
Commault Systems
CVLT
$6.1B
| $792K | ﹤0.01% |
13,400
-8,700
| -39% | -$513K |
|
5507
CALL
Fomento Económico Mexicano
FMX
$40.3B
| $792K | ﹤0.01% |
9,200
-15,800
| -63% | -$1.4M |
|
5508
State Street SPDR Global Dow ETF
DGT
$630M
| $791K | ﹤0.01% |
10,478
+3,073
| +41% | +$247K |
|
|
DQ
5509
CALL
Daqo New Energy
DQ
$991M
| $791K | ﹤0.01% |
169,000
-34,000
| -17% | -$167K |
|
5510
CALL
PetMed Express
PETS
$39.5M
| $791K | ﹤0.01% |
34,000
+9,700
| +40% | +$259K |
|
|
SCHV
5511
Schwab US Large-Cap Value ETF
SCHV
$16.3B
| $791K | ﹤0.01% |
48,156
-23,346
| -33% | -$413K |
|
|
ACOR
5512
PUT
DELISTED
Acorda Therapeutics
ACOR
| $791K | ﹤0.01% |
423
-204
| -33% | -$444K |
|
|
NBL
5513
PUT
DELISTED
Noble Energy, Inc.
NBL
| $790K | ﹤0.01% |
42,100
-62,600
| -60% | -$1.6M |
|
5514
ProShares MSCI EAFE Dividend Growers ETF
EFAD
$64M
| $789K | ﹤0.01% |
23,635
+17,245
| +270% | +$608K |
|
5515
PUT
Hecla Mining
HL
$12.3B
| $788K | ﹤0.01% |
333,900
+69,700
| +26% | +$178K |
|
5516
PUT
Jefferies Financial Group
JEF
$12.7B
| $788K | ﹤0.01% |
50,718
-4,021
| -7% | -$73.6K |
|
5517
CALL
Enanta Pharmaceuticals
ENTA
$383M
| $786K | ﹤0.01% |
11,100
-1,500
| -12% | -$115K |
|
5518
CALL
Heron Therapeutics
HRTX
$63.9M
| $786K | ﹤0.01% |
30,300
-25,700
| -46% | -$707K |
|
5519
KALA BIO
KALA
$18.3M
| $786K | ﹤0.01% |
+64
| New | +$1.11M |
|
|
XENT
5520
PUT
DELISTED
Intersect ENT, Inc
XENT
| $786K | ﹤0.01% |
27,900
-4,800
| -15% | -$141K |
|
5521
Acco Brands
ACCO
$401M
| $785K | ﹤0.01% |
115,811
+23,251
| +25% | +$199K |
|
|
AXDX
5522
DELISTED
Accelerate Diagnostics
AXDX
| $785K | ﹤0.01% |
6,822
+1,425
| +26% | +$211K |
|
5523
CALL
KBR
KBR
$4.84B
| $785K | ﹤0.01% |
51,700
-4,200
| -8% | -$78.6K |
|
5524
Tortoise North American Pipeline ETF
TPYP
$886M
| $785K | ﹤0.01% |
39,411
+25,323
| +180% | +$558K |
|
|
COLO
5525
Global X MSCI Colombia ETF
COLO
$215M
| $784K | ﹤0.01% |
25,155
+13,915
| +124% | +$493K |
|
Similar funds
Ken Griffin's Q4 2018 Portfolio in Review
As of Q4 2018, Ken Griffin held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Assurant worth $99.4M.
- Ken Griffin's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
- Ken Griffin added most to Amazon in Q4 2018, an estimated $1.68B increase.
- Ken Griffin's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
- Ken Griffin fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
- Ken Griffin's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
- Ken Griffin opened 1,236 new positions and closed 1,371 in Q4 2018.
- Ken Griffin's portfolio value fell 19% quarter-over-quarter to $183B.
Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.